PATENT CLAIM ANALYSIS

Application Number: 16066852
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "450000"]

Abstract:
Disclosed in the present disclosure is a Dezocine analogue, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Claim (Index 3):
The compound, the pharmaceutically acceptable salt or tautomer thereof according to  claim 2 , wherein R 12  is selected from H, F, Cl, Br, I, CN, OH, NH 2 , Me, and, when X is CH 2 , R 12  is not H.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.26667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16093376', '16087861', '15750704', '16325626', '16326976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082083674597094
- 35 USC 102 Novelty (BERT): 0.5591538626815244
- Combined Prediction Score: 0.7833029169818908
- Mean Citation Score: 424.76278
- Max Citation Score: 435.91037
- Similarity Product: 309.34599387605914

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test